Carlos Rodriguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carlos Rodriguez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Dong Hyun Nam
Department of Chemical and Environmental Engineering, University of California, Riverside 900 University Ave, Riverside, CA 92521, USA
2 shared publications- Xin Ge
University of Texas Health Science Center at Houston
2 shared publications Albert G. Remacle
Inflammatory and Infectious Disease Center and Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037
1 shared publicationAlex Y. Strongin
Inflammatory and Infectious Disease Center and Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037
1 shared publication- Gregor Blaha
Department of Biochemistry, University of California, Riverside, CA 92521, USA
1 shared publication - Kuili Fang
Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL, 60616, USA
1 shared publication
Latest Publications
- 13 May 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (S1)
The Effects of Ribosomal Proteins uS2, uS3, and uS4 on Transcription
In E. coli, transcription and translation are coupled and ribosomes can directly contact RNA polymerase. The contacts are formed between the RNA exit site of the RNA polymerase and ribosomal proteins uS2, uS3, or uS4 on the ribosome. We assessed the effects of ribosomal proteins uS2, uS3, and uS4 on transcription. In varying degrees, they all reduced termination and increased pausing. Although uS2 bound directly to the polymerase, it affected transcription the least. uS3, which did not bind the polymerase, had the most prominent effects on transcription. We suggest uS2 acts as an anchor for the polymerase during coupling of transcription and translation. Likewise, uS3 and uS4 may affect transcription depending on the length of RNA between the ribosome and polymerase. We speculate that ribosomal proteins may also coordinate the transcription of ribosomal RNAs with their assembly into ribosomes. Finally, we submit that the intrinsic effects of ribosomal proteins may drive the tight regulation of their expression in the cell.
- 13 May 2022
- Published by Wiley in The FASEB Journal
- Vol. 36 (S1)
The Effects of Ribosomal Proteins uS2, uS3, and uS4 on Transcription
In E. coli, transcription and translation are coupled and ribosomes can directly contact RNA polymerase. The contacts are formed between the RNA exit site of the RNA polymerase and ribosomal proteins uS2, uS3, or uS4 on the ribosome. We assessed the effects of ribosomal proteins uS2, uS3, and uS4 on transcription. In varying degrees, they all reduced termination and increased pausing. Although uS2 bound directly to the polymerase, it affected transcription the least. uS3, which did not bind the polymerase, had the most prominent effects on transcription. We suggest uS2 acts as an anchor for the polymerase during coupling of transcription and translation. Likewise, uS3 and uS4 may affect transcription depending on the length of RNA between the ribosome and polymerase. We speculate that ribosomal proteins may also coordinate the transcription of ribosomal RNAs with their assembly into ribosomes. Finally, we submit that the intrinsic effects of ribosomal proteins may drive the tight regulation of their expression in the cell.
- Open Access
- 15 December 2016
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 30 (2) , 113-118
Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization
Matrix metalloproteinase-14 (MMP-14) plays important roles in cancer metastasis, and the failures of broad-spectrum MMP compound inhibitors in clinical trials suggested selectivity is critical. By grafting an MMP-14 specific inhibition motif into complementarity determining region (CDR)-H3 of antibody scaffolds and optimizing other CDRs and the sequences that flank CDR-H3, we isolated a Fab 1F8 showing a binding affinity of 8.3 nM with >1000-fold enhancement on inhibition potency compared to the peptide inhibitor. Yeast surface display and fluorescence-activated cell sorting results indicated that 1F8 was highly selective to MMP-14 and competed with TIMP-2 on binding to the catalytic domain of MMP-14. Converting a low-affinity peptide inhibitor into a high potency antibody, the described methods can be used to develop other inhibitory antibodies of therapeutic significance.
- 15 December 2016
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 30 (2) , 113-118
Open AccessGeneration of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization
Matrix metalloproteinase-14 (MMP-14) plays important roles in cancer metastasis, and the failures of broad-spectrum MMP compound inhibitors in clinical trials suggested selectivity is critical. By grafting an MMP-14 specific inhibition motif into complementarity determining region (CDR)-H3 of antibody scaffolds and optimizing other CDRs and the sequences that flank CDR-H3, we isolated a Fab 1F8 showing a binding affinity of 8.3 nM with >1000-fold enhancement on inhibition potency compared to the peptide inhibitor. Yeast surface display and fluorescence-activated cell sorting results indicated that 1F8 was highly selective to MMP-14 and competed with TIMP-2 on binding to the catalytic domain of MMP-14. Converting a low-affinity peptide inhibitor into a high potency antibody, the described methods can be used to develop other inhibitory antibodies of therapeutic significance.
- 13 December 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (52) , 14970-14975
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Proteases are frequent pharmacological targets, and their inhibitors are valuable drugs in multiple pathologies. The catalytic mechanism and the active-site fold, however, are largely conserved among the protease classes, making the development of the selective inhibitors exceedingly challenging. In our departure from the conventional strategies, we reviewed the structure of known camelid inhibitory antibodies, which block enzyme activities via their unusually long, convex-shaped paratopes. We synthesized the human Fab antibody library (over 1.25 × 109 individual variants) that carried the extended, 23- to 27-residue, complementarity-determining region (CDR)–H3 segments. As a proof of principle, we used the catalytic domain of matrix metalloproteinase-14 (MMP-14), a promalignant protease and a drug target in cancer, as bait. In our screens, we identified 20 binders, of which 14 performed as potent and selective inhibitors of MMP-14 rather than as broad-specificity antagonists. Specifically, Fab 3A2 bound to MMP-14 in the vicinity of the active pocket with a high 4.8 nM affinity and was similarly efficient (9.7 nM) in inhibiting the protease cleavage activity. We suggest that the convex paratope antibody libraries described here could be readily generalized to facilitate the design of the antibody inhibitors to many additional enzymes.
- 13 December 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (52) , 14970-14975
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Proteases are frequent pharmacological targets, and their inhibitors are valuable drugs in multiple pathologies. The catalytic mechanism and the active-site fold, however, are largely conserved among the protease classes, making the development of the selective inhibitors exceedingly challenging. In our departure from the conventional strategies, we reviewed the structure of known camelid inhibitory antibodies, which block enzyme activities via their unusually long, convex-shaped paratopes. We synthesized the human Fab antibody library (over 1.25 × 109 individual variants) that carried the extended, 23- to 27-residue, complementarity-determining region (CDR)–H3 segments. As a proof of principle, we used the catalytic domain of matrix metalloproteinase-14 (MMP-14), a promalignant protease and a drug target in cancer, as bait. In our screens, we identified 20 binders, of which 14 performed as potent and selective inhibitors of MMP-14 rather than as broad-specificity antagonists. Specifically, Fab 3A2 bound to MMP-14 in the vicinity of the active pocket with a high 4.8 nM affinity and was similarly efficient (9.7 nM) in inhibiting the protease cleavage activity. We suggest that the convex paratope antibody libraries described here could be readily generalized to facilitate the design of the antibody inhibitors to many additional enzymes.